Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

著者: Esther Aguilar, Biagio Ricciuti, Justin F. Gainor, Kenneth L. Kehl, Sasha Kravets, Suzanne E. Dahlberg, Mizuki Nishino, Lynette M. Sholl, Anika E. Adeni, S. Subegdjo, S. Khosrowjerdi, Rachel Peterson, Subba R. Digumarthy, C. Liu, Jennifer L. Sauter, Hira Rizvi, Kathryn C. Arbour, B.W. Carter, John V. Heymach, Mehmet Altan, Matthew D. Hellmann, Mark M. Awad - Annals of Oncology 2019 被引用: 336